H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 12 (2) , 91.e1-91.e7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Urothelial Tumors of the Urinary Bladder in Young Patients: A Clinicopathologic Study of 59 CasesArchives of Pathology & Laboratory Medicine, 2013
- Transitional cell carcinoma of the bladder in children and adolescents: Six-case series and review of the literatureJournal of Pediatric Urology, 2010
- UROTHELIAL NEOPLASMS IN PATIENTS 20 YEARS OR YOUNGER: A CLINICOPATHOLOGICAL ANALYSIS USING THE WORLD HEALTH ORGANIZATION 2004 BLADDER CONSENSUS CLASSIFICATIONJournal of Urology, 2005
- Superficial Bladder Tumors in Patients under 40 Years of Age: Clinical, Prognostic and Cytogenetic AspectsUrologia Internationalis, 2001
- THE MOLECULAR CHARACTERISTICS OF BLADDER CANCER IN YOUNG PATIENTSJournal of Urology, 1998
- Carcinoma of the Bladder in Patients Under 25 Years of AgeScandinavian Journal of Urology and Nephrology, 1996
- Transitional Cell Carcinoma of the Bladder in the Pediatric PatientJournal of Urology, 1996
- Long-Term Followup of Patients Less Than 30 Years Old with Transitional Cell Carcinoma of BladderJournal of Urology, 1988
- Transitional Cell Carcinoma of the Bladder in Children and AdolescentsJournal of Urology, 1983
- Primary Epithelial Tumors of the Bladder in the first two Decades of LifeJournal of Urology, 1969